Preliminary studies show conolidine may possibly inhibit certain ion channels, reducing neuronal excitability and restricting pain indicators. This system is particularly relevant in neuropathic suffering, in which abnormal signaling will cause persistent irritation. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to soreness https://katherineu681awy3.blog-gold.com/profile